吉林怎么可以使阴茎增大增粗吉林包皮医院在哪,吉林小鸡鸡根部部长了个小疙瘩,吉林包皮过长医院预约,吉林男科病睾丸炎的治疗医院,吉林男科专科医院哪家最好,吉林治性功能障碍方法,吉林阴茎勃起不持久是怎么回事

BEIJING, Nov. 22 (Xinhuanet) -- Underweight patients may have more possibilities of mortality within 30 days of general and vascular surgery compared with mildly obese patients, according to a research published online in Archives of Surgery Tuesday.Researchers at the U.S. National Surgical Quality Improvement Program conducted the research for the years 2005 and 2006, and assessed the contribution of BMI (Body Mass Index) to 189,533 postsurgeries morbidity and mortality by obesity classes.They found that compared with the middle BMI quintile group, patients with BMI value below 23.1, had greater chances for death. For the highest BMI quintile group, higher mortality rate was also observed.However, the researchers also found that obesity may as well be associated with increased mortality for some individual types of surgeries."These individual types of procedures include procedures with which the general surgeon should have definite experience: colorectal resection, colostomy formation, cholecystectomy, hernia repair, mastectomy, and wound debridement," said George J. Stukenborg, PhD, of the University of Virginia inCharlottesvilleand his colleagues.Based on a 30 –day morbidity and mortality risk calculation, the sample patients were categorized into BMI quintile ranges. BMI value of less than 23.1 was considered as lowest, values from 26.3 to 29.6 considered as the middle quintile, and above 35.2 considered as the highest.Factors such as lack of enough data on nonfatal complications and hospital resources, or examining mortality over the 30-day baseline, may cause limitations and inaccuracy to the research and more studies on a wider range of patients in terms of BMI are needed to further confirm the current conclusion, researchers said.

UNITED NATIONS, Nov. 18 (Xinhua) -- China on Friday voiced its hope that countries concerned "will continue to appropriately address the issue" of the alleged plot to kill Saudi Arabian ambassador to the United States "through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf region."The statement came as Li Baodong, Chinese permanent representative to the United Nations, was addressing the UN General Assembly to explain the Chinese position on the issue after he abstained from voting on the draft resolution on the alleged Iranian involvement in the assassination plot."China hopes countries concerned will continue to appropriately address the issue through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf region," he said."At present, the case is highly complicated and sensitive," Li said. "Parties still have different views over the issue. Any conclusion or action must be based on comprehensive, impartial, objective and transparent investigation and substantial evidence.""Before facts are out, parties should adopt a prudent approach, refrain from jumping to conclusions, and avoid action that may complicate and worsen the situation," he said."China abstained from the vote on the General Assembly draft resolution entitled 'Terrorist Attacks on Internationally Protected Persons'," he said. "We oppose all forms of terrorism, and always stand for compliance with international law and the basis norms governing international relations in handling state-to- state relations as well as effective protection of the safety and security of diplomatic personnel."Earlier on Friday, the UN General Assembly adopted a resolution which expressed deep concerns at the assassination plot and called on Iran "to comply with all of its obligations under international law." Iran strongly denied the allegation.Before or after the vote, countries such as Bolivia, Sudan and Venezuela said that due to a lack of solid evidence to support the allegation, the draft adoption would "create a dangerous precedent " in the international relations.

BEIJING, Oct. 12(Xinhuanet) -- People allergic to peanuts may find relief in a new research by American scientists, according to Huffington Post Monday.Scientists from the Northwestern University Feinberg School of Medicine have found a way to turn off allergic responses by creating an immune system tolerant to peanuts.They attached peanut proteins, the source of the allergy, to white blood cells of mice. Then the mice's immune systems would recognise the proteins and become tolerant to them.When people eat peanuts, allergic human bodies would recognize peanut proteins as invading pathogens and trigger immune responses like throat swelling, even closing up, which can be lethal. Ditto for mice's bodies.But when peanut protein attached to the body's own cells, the immune systems would regard the peanut proteins as perfectly normal and not attack the cells, said Paul Bryce, an assistant professor involved in the study. Then the allergic responses disappeared.The research was conducted on mice. But the scientists expected the method to cure peanut allergies could apply to humans, according to Huffington Post.Although the research was promising, it did not mean that peanut allergies in humans could be actually cured in the foreseeable future, said Dr. Clifford Basset medical director at Allergy and Asthma Care of New York, to ABC News, "Its all about education, prevention and preparedness".

COPENHAGEN, Nov. 3 (Xinhua) -- The launch of Shenzhou-8 and the successful docking with Tiangong-1 in outer space represented a milestone in both Chinese and international space programs, Danish space scientist and media said Thursday.Michael Linden-Voernle, an astrophysicist at the Tycho Brahe Planetarium in Copenhagen, said new possibilities have opened for both Chinese and international space programs with high expectations."The recent launch of the Tiangong-1 module and now the successful docking with the Shenzhou-8 spacecraft is a very important step - a milestone for the Chinese space program in order to realize the goal of having a permanent presence in space. That means a large space station so this is really an important step, a major milestone," Linden-Voernle told Xinhua in an interview here on Thursday.Besides, a number of Danish news media reported the event, hailing it as a "historic and successful docking." The influential daily Politiken placed a two-minute's video for the successful coupling on its website and showed scenes from the Shenzhou-8 docking with Tiangong-1 together with a short commentary."Tonight two Chinese spacecraft made the historic and successful docking above the atmosphere for the first time ever. China had been the third country in the world after the United States and Russia to master the technique of docking in space. China has laid the foundation for its dominance in space," Politiken said.Jyllands-Posten, one of the bestselling newspapers in Denmark, carried a report with a brief description of China's first space docking under the headline "China closer to its own space station.""As the third country in the world, China has docked two spacecraft together perfectly in space," said Jyllands-Posten.China's unmanned spacecraft Shenzhou-8 and its space lab module Tiangong-1 rendezvoused early Thursday, successfully completing the country's first-ever space docking.

WASHINGTON, Nov. 24 (Xinhua) -- An inexpensive drug that treats Type 2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type 2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.The research appeared online this week in PLoS One.For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells. Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene. Then the mammospheres were exposed to natural estrogen -- a known growth factor and potential breast tumor promoter -- and man-made chemicals that are known to promote tumors or disrupt the endocrine system.The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases."While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers," Trosko said.